Project description
Several studies have highlighted that targeting or modulating MHC class II antigen presentation can be beneficial for T1D pathology control. This proposal has the potential not only to reveal novel aspects of MHC class II antigen presentation but also to enhance its targeting in unhealthy states associated with autoimmunity.